Dilated cardiomyopathy in dystrophic epidermolysis bullosa

Archives of Disease in Childhood

Volumn 83, Issue 1, 2000, Pages 59-63

  Sidwell, R U ^a   Yates, R ^a   Atherton, D ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Dilated cardiomyopathy; Dystrophic epidermolysis bullosa

Indexed keywords

CARNITINE; SELENIUM; TRACE ELEMENT;

ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; HEART DILATATION; HEART FUNCTION; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; SCREENING;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CARNITINE; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENES, RECESSIVE; HUMANS; INFANT; SELENIUM;

EID: 0033925197     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.83.1.59     Document Type: Article

References (16)

1. 1 Uitto J, Pulkkinen L. Molecular complexity of the cutaneous basement membrane zone. Mol Biol Rep 1996;23:35-46.
2. 2 Jarvikallio A, Pulkkinen L, Uitto J. Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat 1997;10:338-47.
3. 3 Haynes L, Atherton DJ, Ade-Ajayi N, Wheeler R, Kiely EM. Gastrostomy and growth in dystrophic epidermolysis bullosa. Br J Dermatol 1996;134:872-9.
4. 4 Melville C, Atherton D, Burch M, Cohn A, Sullivan I. Fatal cardiomyopathy in dystrophic epidermolysis bullosa. Br J Dermatol 1996;135:603-6.
5. 5 Brook MM, Weinhouse E, Jarenwattanon M, Nudel DB. Dilated cardiomyopathy complicating a case of epidermolysis bullosa dystrophica. Pediatr Dermatol 1989;6:21-3.
6. 6 Sharratt GP, Lacson AGS Cornel G, Virmani S. Echocardiography of intracardiac filling defects in infants and children. Pediatr Cardiol 1986;7:189-94.
7. 7 Roe DS, Terada N, Millington DS. Automated analysis for free and short chain acyl carnitine in plasma with a centrifugal analyser. American Association of Clinical Chemistry, 1992:2215-20.
8. 8 Zales VR, Benson DW. Reversible cardiomyopathy due to carnitine deficiency from renal tubular wasting. Pediatr Cardiol 1995:16:76-8.
9. 9 Squarcia U, Agnetti A, Caffarra A, Cavalli C, Marbini A. Dilated cardiomyopathy due to primary carnitine deficiency. Pediatr Med Chir 1986;8:157-61.
10. 10 Kothari SS, Sharma M. L-carnitine in children with idiopathic dilated cardiomyopathy. Indian Heart J 1998;61: 59-61.
11. 11 Marx M, Skyllouriotis M, Legenstein E, Proll E, Wimmer M. Plasma carnitine status: a prognostic factor in children with dilated cardiomyopathy. Amino Acids 1997:12:157-66.
12. 12 Li Y, Nan BS. Correlation of selenium, glutathione peroxidase activity and lipoperoxidation rates in dilated cardiomyopathy. Chin Med J 1989;102:670-1.
13. 13 Li GS, Wang F, Kang D, Li C. Keshan disease: an endemic cardiomyopathy in China. Hum Pathol 1985;16:602-9.
14. 14 Attas M, Hanley HG, Stultz D, Jones MR, McAllister RG. Fulminant beriberi heart disease with lactic acidosis: presentation of a case with evaluation of left ventricular function and review of pathophysiologic mechanisms. Circulation 1978;58:566-72.
15. 15 Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy-role of viruses, cytokines, and nitric oxide. Jpn Circ J 1997;61:275-91.
16. 16 Muller S. Dilated cardiomyopathy - heart muscle disease of unknown origin or an autoimmune disease? New aspects of etiology, pathogenesis and clinical practice. Z Gesamte Inn Med 1989;44:469-76.